Pliant Therapeutics (PLRX) Other financing activities (2019 - 2020)
Pliant Therapeutics (PLRX) reported Other financing activities of -$8000.0 for Q4 2020, down 100.31% year-over-year from $2.6 million in Q1 2020, and down 366.67% quarter-over-quarter from $3000.0 in Q3 2020.
Pliant Therapeutics (PLRX) Other financing activities (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has 2 years of Other financing activities data on file, last reported at -$8000.0 in Q4 2020.
- Other financing activities for Q4 2020 came in at -$8000.0, down 100.31% year-over-year; the trailing twelve-month figure through Sep 2022 was -$8000.0 (down 100.0% YoY), and the FY2022 annual result was $150000.0, changed N/A from the prior year.
- Other financing activities fell to -$8000.0 in Q4 2020 per PLRX's latest filing, from $3000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $2.6 million in Q4 2019 and troughed at -$8000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -8,000.00 |
| Dec 31, 2020 | -8,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 2.56 Mn |
| Dec 31, 2019 | 2.56 Mn |
| Sep 30, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 9,000.00 |